190 results
8-K
CHRS
Coherus Biosciences Inc
5 Jun 24
Departure of Directors or Certain Officers
9:11am
holds a B.S. in Accounting from Fairleigh Dickinson University.
As a non-employee director, Ms. Karachun will receive compensation in accordance … with the Company’s non-employee director compensation policy. Pursuant to this policy, upon appointment to the Board, Ms. Karachun will be eligible
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
, but excluding any employee benefit plan of such Person or its Subsidiaries, and any Person acting in its capacity as trustee, agent or other fiduciary … to the extent) so converted into Equity Interests.
“ERISA” means the Employee Retirement Income Security Act of 1974, and its regulations.
“ERISA
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
Contracts
Regulatory Compliance
Margin Stock
Subsidiaries; Capitalization
Employee Matters
Full Disclosure
FCPA; Patriot Act; OFAC
Health Care Matters … 4.15 of the Disclosure Letter, each Credit Party is a Registered Organization.
4.16.Employee Matters. Neither Borrower nor any of its Subsidiaries
DEFA14A
CHRS
Coherus Biosciences Inc
13 May 24
Additional proxy soliciting materials
4:35pm
currently have in place under which we can grant awards (other than the shares available for purchase under our 2014 Employee Stock Purchase Plan
8-K
EX-99.1
6evysw9 fk4e489cy
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
8-K
EX-99.1
2on5 4myyiip7u
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
lkev5za
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-2.1
4cm79idet8er5kwhhhk4
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
gxz60
11 Dec 23
Departure of Directors or Certain Officers
4:13pm